Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial
PaperCitations, authors & open-access status
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 65 citations, 2025 year and closed oa status.
65
Citations
2025
Year
closed
OA Status